- Published at
- by investing.com
positive
positive
Relief Therapeutics Secures up to $11 Million from Royalty Sales By Investing.com
Relief Therapeutics Secures up to $11 Million from Royalty Sales
News for Acer Therapeutics Inc. (ACER)
- Published at
- by globenewswire.com
neutralneutralAnavex Life Sciences Announces Expansion of Leadership Team
Strengthening Operational Efficiency and Execution towards Sustainable Accessibility for Diverse Populations within Global Healthcare Systems...- Published at
- by globenewswire.com
neutralneutralZevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Launch of OLPRUVA® underway Topline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH symptoms Q4 2023 net revenue...- Published at
- by globenewswire.com
mixedmixedTScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...- Published at
- by globenewswire.com
mixedmixed- Published at
- by marketscreener.com
neutralneutralAcer Therapeutics Inc.(OTCPK:ACER) dropped from S&P TMI Index -November 13, 2023 at 12:00 am EST
Acer Therapeutics Inc. dropped from S&P TMI Index...- Published at
- by globenewswire.com
positivepositiveZevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results
Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results....- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIN, TWNK, PNT, ACER
NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, AVTA, SPLK, ACER
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by marketscreener.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN -September 18, 2023 at 11:43 pm EDT
NEW YORK, Sept. 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...- Published at
- by prnewswire.com
mixedmixedUrea Cycle Disorder Treatment Market to grow by USD 235.5 million from 2022-2027 | North America to account for 36% of market growth - Technavio
/PRNewswire/ -- The urea cycle disorder treatment market size is expected to grow by USD 235.5 million from 2022 to 2027. In addition, the momentum of the...- Published at
- by globenewswire.com
positivepositiveBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasd
BALA CYNWYD, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...- Published at
- by marketscreener.com
positivepositiveRelief Therapeutics Holding AG Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics
Relief Therapeutics Holding AG announced it has entered into a new exclusive definitive licensing agreement with Acer Therapeutics Inc. for the development and commercialization of OLPRUVA? for the...- Published at
- by benzinga.com
mixedmixedGold Rises Over 1%; Elys Game Technology Shares Spike Higher - Acer Therapeutics (NASDAQ:ACER), Elys Game Technology (NASDAQ:ELYS)
U.S. stocks traded mixed toward the end of trading, with the Dow Jones trading slightly higher on Tuesday.- Published at
- by benzinga.com
mixedmixed- Published at
- by marketscreener.com
positivepositiveAcer Therapeutics Gets FDA Approval for Lead Drug Candidate Olpruva
By Mary de Wet Acer Therapeutics Inc. has received approval from the Food and Drug Administration for Olpruva, the first of four drugs the company was investigating. The drug, also known... | December 23, 2022- Published at
- by globenewswire.com
mixedmixedPost-traumatic Stress Disorder Clinical Trials Pipeline Analysis: 25+ Companies are Working to Improve the Treatment Space | DelveInsight
DelveInsight’s post-traumatic stress disorder pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies for...- Published at
- by marketscreener.com
mixedmixedRelief Reports Half-Year 2022 Results and Provides Corporate Update
Relief Therapeutics Holding SA / Key word: Interim Report Relief Reports Half-Year 2022 Results and Provides Corporate Update 15-Sep-2022 / 07:00 CET/CEST Release of an ad hoc announcement... | September 15, 2022- Published at
- by dandodiary.com
mixedmixedGuest Post: Analysis of Biotech Securities Class Action Motion to Dismiss Results, 2005 – 2022
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech- Published at
- by benzinga.com
mixedmixed95 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.YMTXWVEVRATIGRN.MXTIGRSMFRSHLSSESNSECOSBETRLXQUBTNEONMFMDJHLIDRLIAN.MXLIIQIOM.VGENIFUTUN.MXFUTUFTCIEOSEWEOSEEARDXFDQN.MXDQDIDICISOBZBKTIBGRYWBGRYATIFATHXASPUASPNARHHDARHHAPIANEBAEYE0I74.LZSANYCBD-PAYCBDVYGR.MXVYGRVIEWWVIEWUONEKUONETCMDSQFLSHCRRRGBOWLTHUMAGEVO.MXGEVOENDPCELUARRYACER0Y5F.L0A41.LPRAXNEGGJKSN.MXJKSEFTRCARV